Celsee Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $99M

Celsee General Information

Description

Developer of an integrated comprehensive single-cell analysis product designed to identify, analyze and viably retrieve single cells directly from blood and tissue. The company's platform provide a practical approach to accurately analyze previously undetectable or rare cells to a scale of millions of single cells from an individual sample, enabling users to gently capture and isolate individual cells from heterogeneous blood and tissue suspensions.

Contact Information

Website
www.celsee.com
Formerly Known As
DeNovo Sciences, Denovo Sciences, Inc.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Phoenix Drive
  • Suite 321
  • Ann Arbor, MI 48108
  • United States
+1 (248)
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 100 Phoenix Drive
  • Suite 321
  • Ann Arbor, MI 48108
  • United States
+1 (248)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celsee Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 01-Apr-2020 $99M Completed Generating Revenue
8. Later Stage VC 20-Dec-2019 Completed Generating Revenue
7. Later Stage VC (Series C) 13-Nov-2018 Completed Generating Revenue
6. Later Stage VC 31-May-2018 Completed Generating Revenue
5. Later Stage VC (Series B) 25-Apr-2017 Completed Generating Revenue
4. Early Stage VC (Series A) 30-Sep-2014 Completed Startup
3. Grant 21-Jun-2012 Completed Startup
2. Grant 01-Apr-2012 $500K Completed Startup
1. Grant 08-Dec-2011 $650K Completed Startup
To view Celsee’s complete valuation and funding history, request access »

Celsee Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 24,290,576 $0.001000 8% $0.26 $0.26 1x $0.26 8.23%
To view Celsee’s complete cap table history, request access »

Celsee Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an integrated comprehensive single-cell analysis product designed to identify, analyze and viably retrieve
Other Devices and Supplies
Ann Arbor, MI
40 As of 2020

Bedford, OH
 

Carlsbad, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celsee Competitors (10)

One of Celsee’s 10 competitors is ViewRay, a Formerly VC-backed company based in Bedford, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ViewRay Formerly VC-backed Bedford, OH
Advanced BioMatrix Formerly VC-backed Carlsbad, CA
Nabsys Formerly VC-backed Providence, RI
S2 Genomics Formerly VC-backed Livermore, CA
CivaTech Oncology Venture Capital-Backed Durham, NC
You’re viewing 5 of 10 competitors. Get the full list »

Celsee Patents

Celsee Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11504719-B2 System and method for receiving and delivering a fluid for sample processing Active 12-Mar-2020
US-12623225-B2 System and method for receiving and delivering a fluid for sample processing Active 12-Mar-2020
US-20210283613-A1 System and method for receiving and delivering a fluid for sample processing Active 12-Mar-2020
US-20230059461-A1 System and method for receiving and delivering a fluid for sample processing Active 12-Mar-2020
US-11724256-B2 System and method for automated single cell processing and analyses Active 14-Jun-2019 C12Q1/6813
To view Celsee’s complete patent history, request access »

Celsee Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celsee Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Albany Capital (Australia) Venture Capital Minority
Ann Arbor SPARK Accelerator/Incubator Minority
First Step Fund Not-For-Profit Venture Capital Minority
Invest Detroit Ventures Corporate Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Celsee FAQs

  • When was Celsee founded?

    Celsee was founded in 2010.

  • Where is Celsee headquartered?

    Celsee is headquartered in Ann Arbor, MI.

  • What is the size of Celsee?

    Celsee has 40 total employees.

  • What industry is Celsee in?

    Celsee’s primary industry is Other Devices and Supplies.

  • Is Celsee a private or public company?

    Celsee is a Private company.

  • What is the current valuation of Celsee?

    The current valuation of Celsee is .

  • What is Celsee’s current revenue?

    The current revenue for Celsee is .

  • How much funding has Celsee raised over time?

    Celsee has raised $36.2M.

  • Who are Celsee’s investors?

    , Albany Capital (Australia), Ann Arbor SPARK, First Step Fund, and Invest Detroit Ventures are 5 of 7 investors who have invested in Celsee.

  • Who are Celsee’s competitors?

    ViewRay, Advanced BioMatrix, Nabsys, S2 Genomics, and CivaTech Oncology are some of the 10 competitors of Celsee.

  • When was Celsee acquired?

    Celsee was acquired on 01-Apr-2020.

  • Who acquired Celsee?

    Celsee was acquired by Bio-Rad Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process